About Theon Pharmaceuticals Limited
Data last updated:
Theon Pharmaceuticals Limited is a public limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231CH2005PLC028465. Its GSTIN is 02AACCT2692J1ZC (Himachal Pradesh). The company holds 11 GST registrations, of which 6 are active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹17.44 Cr. It is led by directors including Amit Kumar Bansal (Managing Director) and Manish Bansal (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 29/4 Industrial Area Phase 2, Chandigarh, India – 160002.
As per the financials filed for FY 2025, the company reported a revenue of ₹633.1 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹52.01 Cr (net margin 8.2%) and EBITDA of ₹81.14 Cr (EBITDA margin 12.8%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 7% over five years.
The company has about 700 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 2 brands: Theon Pharma and Theon Pharmaceuticals. As per MCA filings, the company has open charges of ₹281.8 Cr and satisfied charges of ₹35.44 Cr on record. Court records list 141 cases involving the company, including 91 filed by the company and 50 filed against it; 54 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹50 Lakh; the latest was in December 2022. Its 8 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Venus Remedies Limited with revenue of ₹668.84 Cr. The company has 9 MSME Form 1 returns on record between 2019 and 2023, listing 1,250 overdue payments to 88 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website theonpharma.com.
Company details
CIN history
Theon Pharmaceuticals has one previous CIN (Corporate Identification Number): L24231CH2005PLC028465. The current CIN is U24231CH2005PLC028465, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231CH2005PLC028465 | Current |
| L24231CH2005PLC028465 | Previous |
Contact details
Theon Pharmaceuticals Limited's registered office is in Chandigarh, Chandigarh. Its website is theonpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 29/4 Industrial Area Phase 2, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Theon Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Theon Pharmaceuticals operates two associated brands: Theon Pharma and Theon Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical drugs, injectables, and formulations for domestic and international markets. | theonpharma.com | |
| Manufacturer of tablets, capsules, syrup, semi-solids, and injectables | theonpharma.in |
Business activity
The main business activity of Theon Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Theon Pharmaceuticals Limited, buy the company report.
Financials of Theon Pharmaceuticals Limited
FY 2025 filings availableTheon Pharmaceuticals Limited reported revenue of ₹633.1 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 4% growth in the latest year. EBITDA rose 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹81.14 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹52.01 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.8% | ||||
| Net Profit Margin | 8.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Theon Pharmaceuticals Limited, buy the company report.
Board of directors of Theon Pharmaceuticals Limited
Theon Pharmaceuticals has 10 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vidushi Khattar Also directs: Eminent Marcons Private Limited | Director | 20 Nov 2019 | 6 Years 11 Months | Current |
| Amit Kumar Bansal Also directs: Colourkart Packaging Private Limited, Theogen Private Limited, Auto Vogue Private Limited and 2 more | Managing Director | 08 Jul 2005 | 21 Years 3 Months | Current |
| Mukesh Bansal Also directs: Zoevita Lifesciences Limited, Colourkart Packaging Private Limited, Theogen Private Limited and 3 more | Director | 27 May 2005 | 21 Years 4 Months | Current |
| Manish Bansal Also directs: Theogen Private Limited, Auto Vogue Private Limited, Jenisha Enterprises Private Limited and 2 more | Whole-Time Director | 08 Jul 2005 | 21 Years 3 Months | Current |
| Niveta Rampaul Sharma Also directs: Samrat Forgings Limited, Devine Impex Limited, Spray Engineering Devices Limited and 4 more | Additional Director | 01 Feb 2025 | 1 Years 8 Months | Current |
| Puneet Bansal | Whole-Time Director | 10 May 2006 | 20 Years 5 Months | Current |
Peer comparison
Theon Pharmaceuticals Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Venus Remedies Limited | ₹668.84 Cr (FY 2025) | 9.0% | Chandigarh, India | |||
| Tablets (India) Ltd | ₹667.39 Cr (FY 2025) | 9.0% | Chennai, Tamil Nadu, India | |||
| RPG Life Sciences Limited | ₹666.11 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Lincoln Pharmaceuticals Ltd | ₹645.71 Cr (FY 2025) | 5.0% | Ahmedabad, Gujarat, India | |||
| Theon Pharmaceuticals Limitedthis company | ₹633.1 Cr (FY 2025) | ₹52.01 Cr | 8.2% | 4.0% | 700 | Chandigarh, India |
| Kopran Limited | ₹629.2 Cr (FY 2024) | 14.0% | Mumbai, Maharashtra, India | |||
| Malladi Drugs and Pharmaceuticals Limited | ₹626.79 Cr (FY 2025) | -7.0% | Chennai, Tamil Nadu, India | |||
| Samarth Life Sciences Private Limited | ₹624.79 Cr (FY 2025) | 11.0% | Mumbai, Maharashtra, India | |||
| Ra Chem Pharma Limited | ₹621.32 Cr (FY 2021) | 15.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Theon Pharmaceuticals Limited, buy the company report.
Auditor
Theon Pharmaceuticals Limited is audited by ANKIT PURI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANKIT PURI & ASSOCIATES | FY 2023 | 031895N |
Shareholding
The shareholding of Theon Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Theon Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2025 | 101085382 | Others | ₹6 Cr | Open | |
| 05 Mar 2025 | 101066153 | Others | ₹60 Cr | Open | |
| 25 Apr 2024 | 100918987 | Others | ₹30 Cr | Open | |
| 17 Mar 2023 | 100701024 | Hdfc Bank Limited | ₹28.5 Cr | Open | |
| 23 Mar 2022 | 100561057 | Axis Bank Limited | ₹60 Cr | Open |
To see the full charge records of Theon Pharmaceuticals Limited, buy the company report.
Total charge records: 18 View all charges
Deals & funding
Theon Pharmaceuticals Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹50 Lakh; the latest was in December 2022.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2022 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Nov 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Dec 2007 | Funding round | ₹50 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Theon Pharmaceuticals Limited has 141 court cases on record: 91 filed by Theon Pharmaceuticals, 50 filed against it. 54 cases are pending and 87 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 97 | 35 | 46 |
| High courts | 40 | 12 | 8 |
| Supreme Court | 2 | 1 | 0 |
| NCLT | 2 | 2 | 0 |
Cases on record (5 of 141)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Civil suit | Filed by the company against M/S Hestia Pharma Pvt Ltd. | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Addom Pharmaceuticals Pvt Ltd | Pending |
| District court, Bhopal, Madhya Pradesh | Court case (MJC AV) | Filed by the company against Madhya Pradesh Public Health Services Corporation Ltd. Bhopal and 1 other | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S Eurocraze Pharma India Pvt Ltd and 3 others | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Duta Formulations P Ltd and 6 others | Pending |
To see the full case history of Theon Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Theon Pharmaceuticals Limited was last rated by Icra on 14 Jun 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 14 Jun 2021 |
To see the full credit ratings and regulatory alerts of Theon Pharmaceuticals Limited, buy the company report.
MSME payment delays
Theon Pharmaceuticals Limited has 9 MSME Form 1 returns on record between 2019 and 2023, listing 1,250 overdue payments to 88 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 88)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Crystal Packaging Industries | |||
| Symbio Generrics India Private Limited | |||
| Virupaksha Organics Limited | |||
| Om Industries (PM) | |||
| an individual supplier |
To see the full MSME payment records of Theon Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Theon Pharmaceuticals has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Theon Lifesciences Private Limited | U24290HR2021PTC097033 | |
| Theon Wellness Private Limited | U26999CH2018PTC042162 |
To see the full group structure of Theon Pharmaceuticals Limited, buy the company report.
Employees & EPFO
Theon Pharmaceuticals Limited has a workforce of 700 employees on its EPFO records as of Apr 09, 2024, across 2 active EPFO establishments.
GST
Theon Pharmaceuticals has 11 GST registrations: 6 active and 5 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AACCT2692J1ZC | Himachal Pradesh | Active | 01 Jul 2017 |
| 06AACCT2692J1Z4 | Haryana | Active | 16 Aug 2017 |
| 29AACCT2692J1ZW | Karnataka | Active | 05 Nov 2018 |
| 21AACCT2692J1ZC | Odisha | Active | 18 Nov 2018 |
To see the full GST registrations and return filing status of Theon Pharmaceuticals Limited, buy the company report.
Recent activity
Theon Pharmaceuticals Limited has 27 board changes on record since 2005: 13 appointments and 14 cessations. The latest: Aaditya Kumar Bansal was appointed as Director on 10 Nov 2025.
52 earlier events are in the company report.
Frequently asked questions
Theon Pharmaceuticals is an active public limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 May 2005 (21+ years old) and is registered under CIN U24231CH2005PLC028465.
Theon Pharmaceuticals has 10 current directors:
- Amit Kumar Bansal - Managing Director
- Manish Bansal - Whole-Time Director
- Puneet Bansal - Whole-Time Director
- Puran Chand Joshi - Whole-Time Director
- Anshul Bansal - Whole-Time Director
- Vidushi Khattar - Director
- Mukesh Bansal - Director
- Niveta Rampaul Sharma - Additional Director
- Aaditya Kumar Bansal - Director
- Himanshu Bansal - Director
The latest financial statements of Theon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Theon Pharmaceuticals is 02AACCT2692J1ZC, registered in Himachal Pradesh. The company has 11 GST registrations in all, of which 6 are active and 5 are cancelled or inactive. Other active GSTINs include 06AACCT2692J1Z4 (Haryana), 29AACCT2692J1ZW (Karnataka), 21AACCT2692J1ZC (Odisha).
The CIN (Corporate Identification Number) of Theon Pharmaceuticals is U24231CH2005PLC028465. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Theon Pharmaceuticals has 141 court cases on record: 91 filed by the company and 50 filed against it. 54 are pending. Most are in the district courts.
Theon Pharmaceuticals was incorporated on 26 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Chandigarh.
Theon Pharmaceuticals has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹50 Lakh; the latest was in December 2022.
The peers of Theon Pharmaceuticals by revenue are Venus Remedies Limited, Tablets (India) Ltd, RPG Life Sciences Limited, Lincoln Pharmaceuticals Ltd, Kopran Limited and 3 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aaditya Kumar Bansal was appointed as Director on 10 Nov 2025. Himanshu Bansal was appointed as Director on 10 Nov 2025. Niveta Rampaul Sharma was appointed as Additional Director on 01 Feb 2025. Theon Pharmaceuticals has 27 board changes on record in total.
Theon Pharmaceuticals has 9 MSME Form 1 returns on record between 2019 and 2023, listing 1,250 overdue payments to 88 micro and small suppliers. The latest return was filed on 04 Jan 2024.
Theon Pharmaceuticals can be reached through the website theonpharma.com. Its registered office is in Chandigarh, India.